Unity Biotechnology Inc Financial Flexibility Index
Unity Biotechnology Inc financial flexibility index. Unity Biotechnology Inc (UBX) has a Financial Flexibility Index of -0.21x as of March 2025. Free cash flow of $-6.36 Million (operating CF $-6.36 Million minus capex $0.00) represents 0% of total liabilities ($30.55 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Unity Biotechnology Inc (2016–2024)
Financial flexibility index of Unity Biotechnology Inc from 2016 to 2024. Historical Financial Flexibility Index trend for Unity Biotechnology Inc across 9 annual periods. Explore Unity Biotechnology Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Unity Biotechnology Inc Financial Flexibility Index by Year (2016–2024)
Unity Biotechnology Inc financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for Unity Biotechnology Inc. For the full cash flow conversion analysis, see Unity Biotechnology Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.67x | $-20.86 Million | $-20.86 Million | $31.17 Million | ▲ +35.4% |
| 2023 | -1.04x | $-38.64 Million | $-38.65 Million | $37.29 Million | ▼ -17.0% |
| 2022 | -0.89x | $-50.93 Million | $-51.03 Million | $57.50 Million | ▼ -28.6% |
| 2021 | -0.69x | $-44.87 Million | $-45.06 Million | $65.14 Million | ▲ +34.9% |
| 2020 | -1.06x | $-77.69 Million | $-78.33 Million | $73.44 Million | ▲ +54.4% |
| 2019 | -2.32x | $-70.83 Million | $-72.42 Million | $30.51 Million | ▲ +13.3% |
| 2018 | -2.68x | $-55.36 Million | $-56.62 Million | $20.68 Million | ▲ +18.4% |
| 2017 | -3.28x | $-36.67 Million | $-38.36 Million | $11.18 Million | ▼ -3101.8% |
| 2016 | -0.10x | $-14.15 Million | $-16.40 Million | $138.18 Million | — |